Risk-Based USFDA Inspections and the Use of AI Tools in Pharmaceutical Audits
Risk-Based USFDA Inspections and the Use of AI Tools in Pharmaceutical Audits: A Complete Guide for 2026 Last Updated: October 2026 Risk-based inspections and Artificial Intelligence (AI) are important topics in modern pharmaceutical quality management. The USFDA uses risk-based approaches to prioritize inspection activities, while AI-assisted analytics offer opportunities for pharmaceutical companies to identify quality … Read more